Published in Am J Pathol on August 01, 1989
Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc (1990) 1.80
Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol (1997) 0.90
Proceedings of the 2014 National Toxicology Program Satellite Symposium. Toxicol Pathol (2014) 0.79
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. Am J Surg Pathol (1996) 0.79
Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury. Toxicol Pathol (2014) 0.76
A bilayer small diameter in vitro vascular model for evaluation of drug induced vascular injury. Biomicrofluidics (2016) 0.75
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings. J Toxicol Pathol (2010) 0.75
Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem (1962) 12.79
Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev (1972) 5.07
Dopamine receptors in the brain. Science (1975) 1.79
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J Pharmacol Exp Ther (1982) 1.69
A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol (1978) 1.41
A new oral renal vasodilator, fenoldopam. Clin Pharmacol Ther (1983) 1.27
Dopamine and the kidney. Clin Sci (Lond) (1982) 1.23
Endothelial contraction in vivo: a study of the rat mesentery. Virchows Arch B Cell Pathol (1972) 1.07
Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol (1976) 1.06
LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. J Pharmacol Exp Ther (1983) 1.06
Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526. J Pharmacol Exp Ther (1984) 1.05
Vascular labelling with monastral blue B. Stain Technol (1982) 1.04
The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro. Br J Clin Pharmacol (1986) 1.04
4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist. J Med Chem (1985) 1.03
Medial changes in arterial spasm induced by L-norepinephrine. Am J Pathol (1981) 1.03
Cardiovascular response to increasing theophylline concentrations. Eur J Clin Pharmacol (1977) 1.01
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist. Eur J Pharmacol (1985) 0.96
Light and electron microscopic studies on rat arterial lesions induced by experimental arterial contraction. Virchows Arch A Pathol Anat Histol (1979) 0.95
The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system. Biochem J (1988) 0.94
The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs. J Pharmacol Exp Ther (1975) 0.94
Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator. Am J Pathol (1985) 0.93
SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors. Eur J Pharmacol (1985) 0.91
Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides. Eur J Pharmacol (1978) 0.89
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines. J Med Chem (1980) 0.89
Adrenoreceptor blockade in angiotensin-induced hypertension: effect on rat coronary arteries and myocardium. Am J Pathol (1982) 0.87
ACUTE HYPERTENSIVE VASCULAR DISEASE. 1. RELATION BETWEEN BLOOD PRESSURE CHANGES AND VASCULAR LESIONS IN DIFFERENT FORMS OF ACUTE HYPERTENSION. Acta Pathol Microbiol Scand (1964) 0.87
Dopamine induced relaxation of isolated canine renal, mesenteric, and femoral arteries contracted with prostaglandin F2-alpha. Circ Res (1975) 0.87
Actions of dopamine and apomorphine on the vasoconstrictor responses of perfused mesenteric arteries of mouse, rat and rabbit. J Pharm Pharmacol (1981) 0.87
Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs. J Cardiovasc Pharmacol (1980) 0.86
The vascular dopamine receptor : a review. J Pharmacol (1982) 0.85
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J Med Chem (1982) 0.85
Peripheral cardiovascular dopamine receptors. Gen Pharmacol (1977) 0.84
Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. J Am Coll Cardiol (1988) 0.83
Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. Acta Pathol Microbiol Scand A (1981) 0.82
Subchronic toxicity of orally administered (gavage and dosed-feed) theophylline in Fischer 344 rats and B6C3F1 mice. Fundam Appl Toxicol (1988) 0.82
Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside. Am Heart J (1988) 0.82
Potential use of DA1 and DA2 receptor agonists in the treatment of hypertension. Clin Exp Hypertens A (1987) 0.80
Cellular changes in mesenteric arteries and veins after acute perfusions of angiotensin II and vasoactive amines. Blood Vessels (1985) 0.80
Arterial necrosis in the rat produced by methoxamine. J Pathol Bacteriol (1960) 0.80
The pathogenesis of small arterial lesions in nephrectomized rats by the administration of renin. Br J Exp Pathol (1981) 0.79
Acute and subchronic toxicology of LY-195115 in rats and dogs. Toxicol Lett (1987) 0.79
Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists. J Med Chem (1986) 0.77
Dopamine-sensitive adenylate-cyclase in rabbit superior mesenteric artery. Arch Int Pharmacodyn Ther (1984) 0.77
Indirect sympathomimetic activity of dopamine. J Pharm Pharmacol (1983) 0.76
The response of small blood vessels in rat skin and skeletal muscle to repeated application of histamine: a chemical, topographical and electron microscopic study. J Pathol (1985) 0.76
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet (1992) 2.95
The bacterial flagellar cap as the rotary promoter of flagellin self-assembly. Science (2000) 2.52
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Aliment Pharmacol Ther (2015) 2.01
The structure of ribosome-channel complexes engaged in protein translocation. Mol Cell (2000) 1.98
Rotational symmetry of the C ring and a mechanism for the flagellar rotary motor. Proc Natl Acad Sci U S A (1999) 1.86
An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron (1994) 1.77
Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res (1986) 1.58
Structures of bacterial flagellar motors from two FliF-FliG gene fusion mutants. J Bacteriol (2001) 1.52
Development and maintenance of a behavior modification repertoire of cottage attendants through T.V. feedback. Am J Ment Defic (1972) 1.48
Image analysis of helical objects: the Brandeis Helical Package. J Struct Biol (1996) 1.44
The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest (2000) 1.37
Binding specificity of the periplasmic oligopeptide-binding protein from Escherichia coli. J Bacteriol (1986) 1.35
Site of Epstein-Barr virus replication in the oropharynx. Lancet (1979) 1.34
Prophylactic activity of cephalosporins in a mouse model of surgical wound infection. J Antibiot (Tokyo) (1983) 1.32
Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes (2000) 1.22
Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes (2001) 1.15
Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther (2013) 1.11
Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res (2001) 1.09
An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology (1995) 1.08
On the possible causes of the release of material absorbing at 260 m-mu by streptomycin treated E. coli cells (K 12 and B). J Antibiot (Tokyo) (1967) 1.08
Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide. DNA Cell Biol (2001) 1.08
[Release of nucleotides and integrity of the bacterial membrane (E. coli K 12)]. Antibiotica (1966) 1.06
Computer storage of catheterization data--preliminary report of a co-operative study. Br Heart J (1972) 1.06
Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology (2001) 1.05
Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J Comp Neurol (1997) 1.03
Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging (1991) 1.02
Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology (1997) 0.99
Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease. J Am Geriatr Soc (1987) 0.99
Purification and characterization of a periplasmic oligopeptide binding protein from Escherichia coli. J Biol Chem (1985) 0.97
Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. Biochem Biophys Res Commun (2000) 0.96
Three-dimensional structural analysis of tetanus toxin by electron crystallography. J Mol Biol (1988) 0.95
Size of the export channel in the flagellar filament of Salmonella typhimurium. Ultramicroscopy (1993) 0.95
Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest (1998) 0.94
Crystallization and preliminary X-ray diffraction analysis of 11 S acetylcholinesterase. J Biol Chem (1988) 0.94
Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator. Am J Pathol (1985) 0.93
The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol (2001) 0.93
Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol (2005) 0.92
Degradation of 5-hydroxymethylfurfural in honey. J Food Sci (2008) 0.90
Investigation of the feeding effects of melanin concentrating hormone on food intake--action independent of galanin and the melanocortin receptors. Brain Res (1999) 0.89
Age-related differences in susceptibility to renal ischemia in rats. Toxicol Appl Pharmacol (1987) 0.88
Light therapy for managing sleep, behaviour, and mood disturbances in dementia. Cochrane Database Syst Rev (2004) 0.87
Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol (1992) 0.87
Acute respiratory distress in the dog associated with paraquat poisoning. Vet Rec (1977) 0.87
Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials. Pharmacol Toxicol (2001) 0.86
Ranitidine-acetaminophen interaction: effects on acetaminophen-induced hepatotoxicity in Fischer 344 rats. Hepatology (1985) 0.86
Primary biliary cirrhosis and type II autoimmune polyglandular syndrome. Can J Gastroenterol (1999) 0.85
Comparative mammalian metabolism of adriamycin and daunorubicin. Cancer Res (1978) 0.85
A membrane-impermeant, cleavable cross-linker. Dimers of human erythrocyte band 3 subunits cross-linked at the extracytoplasmic membrane face. J Biol Chem (1981) 0.85
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies. Hum Exp Toxicol (2000) 0.85
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse (1991) 0.85
Cryo electron microscopy of unstained, unfixed RecA-cssDNA complexes. J Ultrastruct Mol Struct Res (1988) 0.84
A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology. Pharm Res (2000) 0.84
Melatonin for cognitive impairment. Cochrane Database Syst Rev (2006) 0.84
Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra. Brain Res Mol Brain Res (1989) 0.83
Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging. Brain Res Mol Brain Res (1992) 0.83
Morphological confirmation of the herpes nature of a carcinogenic virus of primates (Herpes saimiri). Nature (1970) 0.82
The subacute and chronic toxicity of SK&F 36914, SK&F D-39162 and gold sodium thiomalate in rats. Vet Pathol Suppl (1978) 0.82
Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res (1984) 0.82
Bile duct adenoma with oncocytic features. Histopathology (2006) 0.81
Pathology of acute respiratory distress in the dog associated with paraquat poisoning. J Comp Pathol (1978) 0.81
Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine. J Neurochem (1990) 0.81
Repair kinetics of DNA, RNA and proteins in the tissues of mice treated with doxorubicin. Arzneimittelforschung (1979) 0.81
Analysis of the pharmacokinetic characteristics, pharmacological and chemotherapeutic activity of 14-Hydroxy-daunomycin (Adriamycin), a new drug endowed with an antitumour activity. Arzneimittelforschung (1971) 0.81
Systemic nickel allergy: oral desensitization and possible role of cytokines interleukins 2 and 10. Int J Immunopathol Pharmacol (2013) 0.81
Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging. Neurobiol Aging (1987) 0.81
Induction of presenilins in the rat brain after middle cerebral arterial occlusion. Brain Res Bull (1999) 0.80
The presence of islet amyloid polypeptide/calcitonin gene-related peptide/salmon calcitonin binding sites in the rat nucleus accumbens. Eur J Pharmacol (1994) 0.80
Peripartum cardiomyopathy. A review. Minerva Ginecol (2003) 0.80
Morphological observations on the replication of herpesvirus saimiri in monkey kidney cell cultures. J Gen Virol (1976) 0.80
Unusual intranuclear tubular structures associated with the maturation of Herpesvirus saimiri in monkey kidney cell cultures. Br J Cancer (1973) 0.80
Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat. Toxicol Pathol (1989) 0.79
The dopamine and serotonin systems during aging in human and rodent brain. A brief review. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.79
Senescent change in tissue weight and immunoreactive beta-endorphin, enkephalin, and vasopressin in eight regions of C57BL/6J mouse brain and pituitary. Neurobiol Aging (1985) 0.79
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci U S A (1997) 0.79
RNA and protein metabolism in the aging brain. Annu Rev Neurosci (1990) 0.79
Dissecting aneurysm of the aorta in a gorilla. Vet Rec (1970) 0.78
Assessment of the exposure to Allura Red colour from the consumption of red juice-based and red soft drinks in Italy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.78
PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure. Environ Health Perspect (1996) 0.78
The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog. J Rheumatol (1988) 0.78
Evidence that a 41,000 dalton brain phosphoprotein is pyruvate dehydrogenase. Biochem Biophys Res Commun (1980) 0.78
Effects of sensitization to dinitrochlorobenzene (DNCB) on clinical pathology parameters and mitogen-mediated blastogenesis in cynomolgus monkeys (Macaca fascicularis). Toxicol Pathol (1990) 0.78
Oral versus transdermal selegiline: antidepressant-like activity in rats. Pharmacol Biochem Behav (1999) 0.78
Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeys. Am J Pathol (1992) 0.78
Distribution of three nicotinic receptor alpha 4 mRNA transcripts in rat brain: selective regulation by nicotine administration. J Neurochem (1996) 0.77
Design and synthesis of new bifunctional sigma-1 selective ligands with antioxidant activity. J Med Chem (2013) 0.77
Enhanced glial fibrillary acidic protein RNA response to fornix transection in aged mice. J Neurochem (1995) 0.77
Recombinant human soluble CD4 does not inhibit immune function in cynomolgus monkeys. Toxicol Pathol (1991) 0.77
New derivatives of 2H-1,3-benzoxazine with anti-bacterial activity. Arzneimittelforschung (1965) 0.77
[3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites. J Neurochem (1986) 0.77
A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity. Mech Ageing Dev (2000) 0.77
Observations on the antigenic relationships between Epstein-Barr virus and herpesvirus saimiri. J Gen Virol (1977) 0.77
Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol (2000) 0.77
Uptake of human recombinant tissue-type plasminogen activator by rat hepatocytes in vivo: an electron microscope autoradiographic study. Thromb Res (1989) 0.76
Alteration of calmodulin distribution does not accompany dopaminergic supersensitization of the mouse striatum. J Neurosci Res (1987) 0.76
Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutat Res (1993) 0.76
The incorporation of intrastriatally injected [3H]fucose into electrophoretically separated synaptosomal glycoproteins. II. The influence of passive avoidance training. Brain Res (1979) 0.76